Related Experiment Video
Updated: Dec 2, 2025

09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
200
MicroRNAs: Multifaceted Regulators of Colorectal Cancer Metastasis and Clinical Applications
Xiang-Qiong Wen1, Xian-Ling Qian2,3, Huan-Kui Sun1
1Department of General Surgery, The First Affiliated Hospital of Nanchang University; Medical College of Nanchang University, Nanchang, Jiangxi, 330006, People's Republic of China.
Oncotargets and Therapy
|November 5, 2020
Summary
MicroRNAs (miRNAs) play a crucial role in colorectal cancer (CRC) metastasis. This review details how miRNAs influence CRC progression and resistance, offering insights for clinical treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a leading cause of cancer death, primarily due to metastasis.
- Metastasis is a complex, multi-step process involving intricate biological pathways.
- MicroRNAs (miRNAs), small noncoding RNAs, are increasingly recognized for their role in cancer development.
Purpose of the Study:
- To review and summarize the multifaceted roles of miRNAs in colorectal cancer metastasis.
- To elucidate the involvement of miRNAs and associated signaling pathways across various stages of CRC metastasis.
- To explore the potential of miRNAs as diagnostic markers and in overcoming treatment resistance in CRC.
Main Methods:
- Comprehensive literature review of studies on miRNAs and colorectal cancer metastasis.
- Analysis of miRNA involvement in key metastatic processes: invasion, migration, metabolism, epithelial-mesenchymal transition, tumor-microenvironment communication, angiogenesis, anoikis, premetastatic niche formation, and cancer stemness.
- Examination of current research on miRNA applications in CRC diagnostics and therapeutic resistance.
Main Results:
- miRNAs are integral to multiple stages of colorectal cancer metastasis, including invasion, migration, and the epithelial-mesenchymal transition.
- Specific miRNAs and their signaling pathways significantly impact tumor-microenvironment interactions, angiogenesis, and cancer stem cell properties.
- miRNAs show promise as biomarkers for CRC diagnosis and as targets for overcoming clinical treatment resistance.
Conclusions:
- Understanding miRNA mechanisms in CRC progression is vital for developing effective therapeutic strategies.
- miRNAs offer potential as diagnostic tools and therapeutic targets to improve outcomes for colorectal cancer patients.
- This review provides a theoretical foundation for advancing clinical CRC treatment through miRNA-based interventions.
Related Concept Videos
MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs
23.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.4K
lncRNA - Long Non-coding RNAs
9.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K

